The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder

References

• Schaztzberg, AF, Rothschild, AJ. Serotonin activity in psychotic (delusional) major depression. J Clin Psychiatry 1992;53(10 Suppl):52–5.
   Google Scholar
• Anton RF. Urinary free cortisol in psychotic depression. Biol Psychhiatry 1987; 2: 24–34
   Google Scholar
• Rudorfer MV, Hwu H-G, Clayton PJ. Dexamethasone suppression test in primary depression: Significance of family history and psychosis. Biol Psychiatry 1982; 17: 41–8
   PubMedGoogle Scholar
• Mendlewicz J, Charles G, Franckson JM. The dexamethasone suppression test in affective disorder: Relationship to clinical and genetic subgroups. Br J Psychiatry 1982; 141: 464–70
   PubMed Web of Science ®Google Scholar
• Schatzberg AF, Rothschild AJ, Stahl JB, et al. The dexamethasone suppression test: Identification of subtypes of depression. Am J Psychiatry 1983; 140: 88–91
   PubMed Web of Science ®Google Scholar
• Evans DL, Burnett GB, Nemeroff CB. The dexamethasone suppression test in the clinical setting. Am J Psychiatry 1983; 140: 586–9
   PubMed Web of Science ®Google Scholar
• Aberg-Wistedt A, Wistedt B, Bertilsson L. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression (letter). Arch Gen Psychiatry 1985; 42: 925–6
   PubMedGoogle Scholar
• Healy D, O'Halloran A, Carney PA, Leonard BE. Platelet 5-HT uptake in delusional and nondelusinal depressions. J Affective Disord 1986; 10: 233–9
   PubMedGoogle Scholar
• Khan A, Kilts RL, Rapaport MH, Krishnan KR, Brodhead AE, Browns WA. Magnitude of placebo response and drug-placebo differences across psychiatric disorder. Psychol Med 2005; 35: 743–9
   PubMed Web of Science ®Google Scholar
• Woklstra, K. Birger, J. Vamdem, Brpel WW. Verles, RK. Borlemjager, TL. Janzing, JGE, , et al. Pharmacological treatment of unipolar psychotic depression. A randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Presented at APA, Washington DC, 2008.
   Google Scholar
• Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andrsen SW, Van Campen LE, et al. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004; 24: 365–73
   PubMed Web of Science ®Google Scholar
• Spiker, DG, Weiss, JC, Dealy, RS, Griffin, SJ, Hanin, I, Neil, JF, , et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430–6. American Psychiatric Association. Practice guideline for the treatment of major depressive disorder (revision). Am J Psychiatry Suppl 2000;157 Suppl 4.
   PubMed Web of Science ®Google Scholar
• Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry 2003; 64: 959–65
   PubMed Web of Science ®Google Scholar
• Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996; 153: 1631–3
   PubMed Web of Science ®Google Scholar
• Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot double-blind controlled study. J Clin Psychiatry 2000; 61: 26–9
   PubMed Web of Science ®Google Scholar
• Englisch, S, Knopf, U, Scharnholz, B, Kuwilsky, A, Deuschle, M, Zink, M. Duloxetine for major depressive episodes in the course of psychotic disorders: An observational clinical trial. J Psychopharmacol. In press.
   Google Scholar
• Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA. Efficacy of imipramine in psychotic versus nonpsychotic depression. J Clin Psychopharmacol 2008; 28: 166–70
   PubMedGoogle Scholar
• van de Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology (Berl) 2004; 175: 481–6
   PubMedGoogle Scholar
• Spiker DG, Dealy RS, Hanin I, Weiss JC, Kupfer DJ. Treating delusional depressives with amitriptyline. J Clin Psychiatry 1986; 47: 243–6
   PubMedGoogle Scholar
• Spiker DG, Kupfer DJ. Placebo response rates in psychotic and nonpsychotic depression. J Affect Disord 1988; 14: 21–3
   PubMed Web of Science ®Google Scholar
• Bruijn JA, Moleman P, Mulder PG, van den Broek WW, van Hulst AM, van der Mast RC, et al. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology (Berl) 1996; 127: 231–7
   PubMed Web of Science ®Google Scholar
• Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, et al. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 2001; 62: 597–604
   PubMed Web of Science ®Google Scholar
• Künzel, HE, Ackl, N, Hatzinger, M, Held, K, Holsboer-Trachsler, E, Ising, M, , et al. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol – A double-blind multicenter trial. J Psychiatr Res. In press.
   Google Scholar
• First, M, Spitzer, R, Gibbon, M, Williams, JBW. Structured clinical interview for DSM-IV axis I disorders – Patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Fogelson DL, Nuechterlein KH, Asarnow RF, Subotnik KL, Talovic SA. Interrater reliability of the Structured Clinical Interview for DSM-III-R, Axis II: Schizophrenia spectrum and affective Spectrum disorders. Psychiatry Res 1991; 39: 55–63
   PubMed Web of Science ®Google Scholar
• Zanardi R, Franchini F, Gasperini M, Perez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996; 153: 1631–3
   PubMed Web of Science ®Google Scholar
• Gatti F, Bellini L, Gasperini M, Perez J, Zanardi R, Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 1996; 153: 414–16
   PubMed Web of Science ®Google Scholar
• Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: Variable, substantial and growing. JAMA 2002; 287: 1840–7
   PubMed Web of Science ®Google Scholar
• Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J. Relationships between major depressive disorder and comorbid personality disorders. Compr Psychiatry 2005; 46: 266–71
   PubMedGoogle Scholar
• Farabaugh A, Mischoulon D, Fava M., Guyker W, Alpert J. The overlap between personality disorders and major depressive disorder (MDD). Ann Clin Psychiatry 2004; 16: 217–24
   PubMedGoogle Scholar
• Farabaugh A, Mischoulon D, Yeung A, Alpert J, Matthews J, Pava J. Predictors of stable personality disorder diagnoses in outpatients with remitted depression. J Nerv Ment Dis 2002; 190: 248–56
   PubMedGoogle Scholar
• Akiskal HS, Arana GW, Baldessarini RJ, Barreira PJ. A clinical report of thymoleptic-responsive atypical paranoid psychoses. Am J Psychiatry 1983; 140: 1187–90
   PubMedGoogle Scholar
• Fogelson DL, Neuechterlein KH, Asarnow RF, Subotnik KL, Talovicj SA. Interrater reliability of the Structured Clinical Interview for DSM-III-R, Axis II: Schizophrenia spectrum and affective spectrum disorders. Psychiatry Res 1991; 39: 55–63
   PubMed Web of Science ®Google Scholar